| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23, 2026 | SINT Sintx Technologies, Inc. | Moyes Jay M49 | Director | Buy | 1,000 | $2.91 | $2,910.00 | +33.3% | -17.9% | - | |
| Feb 20, 2026 | PODD Insulet Corporation | McEvoy Ashley | President And CEO | Buy | 4,300 | $239.35 | $1,029,205.00 | +44.7% | -35.1% | - | |
| Feb 19, 2026 | CBLL Ceribell, Inc. | Parvizi Josef60 | Director | Sell | 16,714 | $20.27 | $338,792.78 | -2.3% | -10.8% | - | |
| Feb 18, 2026 | ATR Aptargroup, Inc. | Touya Gael61 | Segment President | Sell | 3,500 | $141.35 | $494,738.65 | -11.1% | -19.8% | - | |
| Feb 18, 2026 | PLSE Pulse Biosciences, Inc. | Danahy Kevin Patrick85 | Chief Commercial Officer | Sell | 5,000 | $23.64 | $118,200.00 | -10.4% | -2.0% | - | |
| Feb 18, 2026 | ALGN Align Technology, Inc. | Morici John61 | EVP, Chief Financial Officer | Sell | 7,969 | $189.31 | $1,508,645.66 | -49.2% | -18.7% | - | |
| Feb 18, 2026 | SINT Sintx Technologies, Inc. | Anderson Mark Lewis | Director | Buy | 3,000 | $3.02 | $9,060.00 | +20.0% | -26.7% | - | |
| Feb 17, 2026 | KMTS Kestra Medical Technologies, Ltd. | Webster Brian Daniel60 | See Remarks | Sell | 15,000 | $25.60 | $384,019.60 | -1.3% | -24.0% | - | |
| Feb 17, 2026 | OM Outset Medical, Inc. | Nash Marc83 | EVP Operations R&D &Service | Sell | 1,817 | $3.35 | $6,086.95 | -4.3% | +11.7% | - | |
| Feb 17, 2026 | OM Outset Medical, Inc. | Brottem John L.84 | General Counsel | Sell | 2,842 | $3.35 | $9,520.70 | -7.9% | +11.7% | - | |
| Feb 17, 2026 | OM Outset Medical, Inc. | Trigg Leslie84 | Chair And CEO | Sell | 3,361 | $3.35 | $11,259.35 | -3.2% | +11.7% | - | |
| Feb 13, 2026 | QDEL Quidelortho Corp | Blaser Brian J. | President And CEO | Buy | 10,540 | $23.59 | $248,660.73 | +35.7% | -51.7% | - | |
| Feb 12, 2026 | DXCM Dexcom Inc | Heller Bridgette P62 | Director | Sell | 1,012 | $68.01 | $68,826.12 | -3.7% | -10.0% | - | |
| Feb 12, 2026 | IRIX Iridex Corp | Dizon Romeo R64 | Chief Financial Officer | Buy | 1,500 | $1.43 | $2,145.00 | +1.3% | -25.4% | - | |
| Feb 10, 2026 | STIM Neuronetics, Inc. | Sullivan Keith J61 | President And CEO | Sell | 40,976 | $1.55 | $63,512.80 | -2.5% | +13.4% | - | |
| Feb 10, 2026 | ATR Aptargroup, Inc. | Prieur Marc66 | Segment President | Sell | 2,000 | $137.81 | $275,620.00 | -12.7% | -13.7% | - | |
| Feb 10, 2026 | STIM Neuronetics, Inc. | MacAn William Andrew66 | EVP, CLO And Cs | Sell | 3,485 | $1.55 | $5,401.75 | -0.5% | +13.4% | - | |
| Feb 5, 2026 | SYK Stryker Corp | Stryker Ronda E57 | Director | Sell | 500,000 | $363.44 | $181,719,268.57 | -1.1% | -19.3% | - | |
| Feb 4, 2026 | ABT Abbott Laboratories | Starks Daniel J53 | Director | Buy | 10,000 | $108.73 | $1,087,331.40 | - | -19.4% | - | |
| Feb 4, 2026 | RPID Rapid Micro Biosystems, Inc. | Longitude Capital Partners Ii, LLC | 10% Owner | Sell | 49,000 | $3.88 | $190,090.60 | -100% | -36.2% | - | |
| Feb 4, 2026 | RSMDF Resmed Inc | Farrell Peter C57 | Director | Sell | 2,000 | $251.31 | $502,620.00 | -3.0% | - | - | |
| Feb 4, 2026 | RSMDF Resmed Inc | Rider Michael J50 | Global General Counsel | Sell | 50 | $260.00 | $13,000.00 | -0.5% | - | - | |
| Feb 3, 2026 | IRIX Iridex Corp | Dizon Romeo R64 | Chief Financial Officer | Buy | 2,500 | $1.38 | $3,450.00 | +2.2% | -27.5% | - | |
| Feb 3, 2026 | CBLL Ceribell, Inc. | Foehr David | Senior VP, Finance And Pao | Sell | 5,556 | $20.00 | $111,120.00 | -12.8% | +0.1% | - | |
| Feb 2, 2026 | SIBN Si-Bone, Inc. | Dunn Jeffrey W70 | Director | Sell | 337 | $16.42 | $5,532.09 | -3.3% | -19.3% | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.